On Mar. 11, 2021, the Israel Ministry of Health (MOH), Pfizer and BioNTech announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2.

These data build upon and confirmed previously released data from the MoH demonstrating the vaccineﾒs effectiveness in preventing symptomatic SARS-CoV-2 infections, COVID-19 cases, hospitalizations, severe and critical hospitalizations, and deaths. The latest analysis from the MoH proved that two weeks after the second vaccine dose protection was even stronger ﾖ vaccine effectiveness was at least 97% in preventing symptomatic disease, severe/critical disease and death.